News

Homebuilders also look exposed. “Looking at GICS L4 sub-industry metrics, homebuilders look more vulnerable to a hawkish ...
Rolls-Royce (LON: RR) continues to outperform after a sharp turnaround. Its civil aerospace and power systems divisions ...
Investing.com -- China is considering permitting yuan-backed stablecoins for the first time as part of efforts to increase ...
Investing.com -- Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) stock surged 23% after the FDA lifted a clinical hold on the company’s pivotal Phase 2 trial of RP-A501 for the treatment of Danon disease.
Investing.com - Rubicon Research Limited, a pharmaceutical formulations company, has filed an addendum to its Draft Red Herring Prospectus (DRHP) with SEBI, updating its financial information for FY25 ...